Literature DB >> 22092209

Chronic alcoholism increases the induction dose of propofol.

C Liang1, J Chen, W Gu, H Wang, Z Xue.   

Abstract

BACKGROUND: The present study was designed to investigate the possible effect of chronic alcohol intake on propofol and remifentanil requirements, which was determined by quantifying the 50% (EC(50) ) and 95% (EC(95) ) effective effect-site concentrations for propofol and remifentanil at loss of consciousness (LOC) and after a painful stimulus.
METHODS: Thirty male patients (alcoholic group; n = 30) with chronic alcoholism and 30 patients (control group; n = 30) with a history of small alcohol intake were anaesthetized with propofol and remifentanil by target-controlled infusion. The predicted drug concentrations and Bispectral Index (BIS) values were recorded at LOC and after no response to painful stimuli.
RESULTS: The EC(50) and EC(95) of propofol at LOC in alcoholic group were 3.15 [95% confidence interval (CI), 2.77-3.37] and 4.05 (95% CI, 3.18-5.26) μg/ml, respectively, and those of the control group were 2.21 (95% CI, 1.92-2.86) and 3.04 (95% CI, 2.45-4.64) μg/ml, respectively. The EC(50) and EC(95) of remifentanil measured after no response to painful stimuli in the alcoholic group were 3.02 (95% CI, 2.70-3.38) and 4.98 (95% CI, 4.56-5.89) ng/ml, respectively, and those of the control group were 2.95 (95% CI, 2.68-3.33) and 4.86 (95% CI, 4.55-5.92) ng/ml, respectively. The EC(50) and EC(95) values of propofol at LOC in the control group were significantly lower than that of the alcoholic group.
CONCLUSIONS: These findings suggest that the induction dose requirements of propofol are increased in alcoholic patients anaesthetized with propofol and remifentanil administered by target controlled infusion. 2011 The Authors Acta Anaesthesiologica Scandinavica, 2011 The Acta Anaesthesiologica Scandinavica Foundation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22092209     DOI: 10.1111/j.1399-6576.2011.02497.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  3 in total

1.  Long-term high-risk drinking does not change effective doses of propofol for successful insertion of gastroscope in Chinese male patients.

Authors:  Pei-Pei Hao; Tian Tian; Bin Hu; Wei-Chao Liu; Ying-Gui Chen; Tian-Yu Jiang; Fu-Shan Xue
Journal:  BMC Anesthesiol       Date:  2022-06-16       Impact factor: 2.376

2.  Dexmedetomidine impairs success of patient-controlled sedation in alcoholics during ERCP: a randomized, double-blind, placebo-controlled study.

Authors:  Max Mazanikov; Marianne Udd; Leena Kylänpää; Harri Mustonen; Outi Lindström; Jorma Halttunen; Reino Pöyhiä
Journal:  Surg Endosc       Date:  2013-01-26       Impact factor: 4.584

3.  Baclofen to prevent agitation in alcohol-addicted patients in the ICU: study protocol for a randomised controlled trial.

Authors:  Mickael Vourc'h; Fanny Feuillet; Pierre-Joachim Mahe; Véronique Sebille; Karim Asehnoune
Journal:  Trials       Date:  2016-08-19       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.